Leave message
Can’t find what you’re looking for?
Fill out this form to inquire about our custom protein services!
Inquire about our Custom Services >>
| Project Name | Modality | Therapeutic Area | Indications | Stage | Right Available |
| TNFRⅡ fusion protein（biosimilar） | Fusion/Recombination protein | Immunological disease | Rheumatoid Arthritis,Psoriasis,Ankylosing Spondylitis | NDA/BLA | Global (except China) |
Immobilized Biotinylated Mouse TNF-alpha Protein, His,Avitag (Cat. No. TNA-M82E9) at 1 μg/mL (100 μL/well) on streptavidin (Cat. No. STN-N5116) precoated (0.5 μg/well) plate can bind Mouse TNFR2 Protein, Fc Tag (Cat. No. TN2-M5254) with a linear range of 0.1-2 ng/mL (QC tested).
The purity of Human TNFR2 Protein, Fc,Avitag (Cat. No. TN2-H82F3) is more than 90% and the molecular weight of this protein is around 145-170 kDa verified by SEC-MALS.
| Name | Research Code | Research Phase | Company | Indications | Clinical Trials |
|---|---|---|---|---|---|
| LBL-019 | LBL-019 | Phase 2 Clinical | Nanjing Leads Biolabs Co Ltd | Neoplasms | Details |
| SIM1811-03 | SIM1811-03; SIM0235; SIM-235 | Phase 1 Clinical | Jiangsu Simcere Pharmaceutical Co Ltd | Solid tumours; Lymphoma, T-Cell, Cutaneous | Details |
| HFB-2003(HiFiBiO Therapeutics) | HFB-2003; HFB-200301 | Phase 1 Clinical | HiFiBiO Therapeutics | Carcinoma, Renal Cell; Squamous Cell Carcinoma of Head and Neck; Stomach Neoplasms; Mesothelioma; Sarcoma; Germinoma; Melanoma; Carcinoma, Non-Small-Cell Lung; Uterine Cervical Neoplasms | Details |
This web search service is supported by Google Inc.
A-Z
